Locations
Emeryville, CA, USA · Los Angeles, CA, USA
industry
Biotechnology · DeepTech
Size
51-200 employees
Stage
Series B
founded in
2017
Octant is a therapeutics company focused on developing next-generation small molecule drugs that modulate complex cellular mechanisms driving diseases, particularly those related to protein misfolding and mistrafficking. Utilizing advanced synthetic biology, high-throughput chemistry, and AI/ML technologies, Octant's Navigator platform enables massive experimentation in human cells to unlock novel insights for drug discovery. The company aims to tackle multifactorial diseases by integrating innovative approaches to drug discovery, positioning itself as a leader in the biotech space with a commitment to improving patient outcomes.
Something looks off?On-site & Remote